Editorial: Systems Biological Aspects of Pituitary Tumors.
作者信息
Zhan Xianquan, Desiderio Dominic M
机构信息
Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, China; Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, China; State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, China; The State Key Laboratory of Medical Genetics, Central South University, Changsha, China.
The Charles B. Stout Neuroscience Mass Spectrometry Laboratory, Department of Neurology, College of Medicine, University of Tennessee Health Science Center , Memphis, Tennessee , USA.
出版信息
Front Endocrinol (Lausanne). 2016 Jun 30;7:86. doi: 10.3389/fendo.2016.00086. eCollection 2016.
Abstract
摘要
相似文献
1
Editorial: Systems Biological Aspects of Pituitary Tumors.
Front Endocrinol (Lausanne). 2016 Jun 30;7:86. doi: 10.3389/fendo.2016.00086. eCollection 2016.
2
Exploration of Molecular Network Variations in Different Subtypes of Human Non-functional Pituitary Adenomas.
Front Endocrinol (Lausanne). 2016 Feb 10;7:13. doi: 10.3389/fendo.2016.00013. eCollection 2016.
3
Pituitary Adenoma and the Chemokine Network: A Systemic View.
Front Endocrinol (Lausanne). 2015 Sep 11;6:141. doi: 10.3389/fendo.2015.00141. eCollection 2015.
4
Chemokine stromal cell-derived factor 1alpha induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals.
Mol Pharmacol. 2006 Feb;69(2):539-46. doi: 10.1124/mol.105.015255. Epub 2005 Oct 28.
5
Clinical aspects of molecular biology of pituitary adenomas.
Folia Neuropathol. 2012;50(2):110-7.
6
Protein kinase C (PKC) activity and PKC messenger RNAs in human pituitary adenomas.
Am J Pathol. 1993 Feb;142(2):569-78.
7
Clinical and endocrine aspects of pituitary tumors.
Saudi Med J. 2004 Oct;25(10):1428-32.
8
Network-based analysis of omics with multi-objective optimization.
Mol Biosyst. 2013 Dec;9(12):2971-80. doi: 10.1039/c3mb70327d. Epub 2013 Oct 14.
9
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function.
J Mol Endocrinol. 2007 Mar;38(3):383-9. doi: 10.1677/JME-06-0014.
10
Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.
Front Endocrinol (Lausanne). 2016 May 31;7:54. doi: 10.3389/fendo.2016.00054. eCollection 2016.
引用本文的文献
1
Phosphorylation-Mediated Molecular Pathway Changes in Human Pituitary Neuroendocrine Tumors Identified by Quantitative Phosphoproteomics.
Cells. 2021 Aug 27;10(9):2225. doi: 10.3390/cells10092225.
2
Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas.
EPMA J. 2020 Aug 13;11(3):419-467. doi: 10.1007/s13167-020-00215-0. eCollection 2020 Sep.
3
Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamous cell carcinomas.
EPMA J. 2020 Jan 4;11(1):73-94. doi: 10.1007/s13167-019-00197-8. eCollection 2020 Mar.
4
Editorial: Molecular Network Study of Pituitary Adenomas.
Front Endocrinol (Lausanne). 2020 Feb 18;11:26. doi: 10.3389/fendo.2020.00026. eCollection 2020.
5
Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas.
Front Endocrinol (Lausanne). 2019 Dec 17;10:835. doi: 10.3389/fendo.2019.00835. eCollection 2019.
6
Metabolomics-A Promising Approach to Pituitary Adenomas.
Front Endocrinol (Lausanne). 2019 Jan 17;9:814. doi: 10.3389/fendo.2018.00814. eCollection 2018.
7
Proteomic Analysis of the Human Anterior Pituitary Gland.
OMICS. 2018 Dec;22(12):759-769. doi: 10.1089/omi.2018.0160.
本文引用的文献
1
EPMA position paper in cancer: current overview and future perspectives.
EPMA J. 2015 Apr 15;6(1):9. doi: 10.1186/s13167-015-0030-6. eCollection 2015.
2
Proteomic and functional profiles of a follicle-stimulating hormone positive human nonfunctional pituitary adenoma.
Electrophoresis. 2015 Jun;36(11-12):1289-304. doi: 10.1002/elps.201500006.
3
Pituitary tumors.
Endocrinol Metab Clin North Am. 2015 Mar;44(1):1-9. doi: 10.1016/j.ecl.2014.11.004.
4
A new initiative on precision medicine.
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
5
Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.
BMC Med Genomics. 2014 Dec 24;7:69. doi: 10.1186/s12920-014-0069-6.
6
Identification of the proteomic variations of invasive relative to non-invasive non-functional pituitary adenomas.
Electrophoresis. 2014 Aug;35(15):2184-94. doi: 10.1002/elps.201300590.
7
Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.
EPMA J. 2013 Jan 22;4(1):2. doi: 10.1186/1878-5085-4-2.
8
The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas.
EPMA J. 2010 Sep;1(3):439-59. doi: 10.1007/s13167-010-0028-z. Epub 2010 Jun 29.
9
Systems approaches to biology and disease enable translational systems medicine.
Genomics Proteomics Bioinformatics. 2012 Aug;10(4):181-5. doi: 10.1016/j.gpb.2012.08.004. Epub 2012 Aug 23.
10
Tumor heterogeneity and personalized medicine.
N Engl J Med. 2012 Mar 8;366(10):956-7. doi: 10.1056/NEJMe1200656.
Zotero 插件